Literature DB >> 15756673

Chlamydia trachomatis infection and persistence of human papillomavirus.

Ilvars Silins1, Walter Ryd, Anders Strand, Göran Wadell, Sven Törnberg, Bengt Göran Hansson, Xiaohong Wang, Lisen Arnheim, Viktor Dahl, Daniel Bremell, Kenneth Persson, Joakim Dillner, Eva Rylander.   

Abstract

Human papillomavirus (HPV) persistence is the major cause of cervical cancer, but most HPV infections will not persist and risk factors for HPV persistence are not well known. Chlamydia (C.) trachomatis infection seems to also be associated with cervical cancer. We investigated whether C. trachomatis infection is a risk factor for HPV persistence. In a cohort of 12,527 women participating in a population-based HPV screening trial in Sweden, 6,418 women completed testing for HPV DNA by general primer PCR and typing by reverse dot blot hybridization. On average 19 months later, 303 women that had been HPV-positive and had normal cytology at enrollment completed a new HPV test. Environmental exposures were assessed by an 87-item questionnaire. Previous sexually transmitted infections were also investigated by serology. At follow-up, 44% of the women were positive for the same type of HPV DNA as at enrollment. Persistence correlated with length of follow-up (p < 0.01) and condom use seemed to protect against HPV persistence (p < 0.05). The most significant risk factor for persistent presence of HPV DNA was self-reported history of previous C. trachomatis infection (relative risk in multivariate model = 2.09; 95% confidence interval = 1.05-4.18). We conclude that persistence of oncogenic HPV infections is more likely among women with a previous C. trachomatis infection. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15756673     DOI: 10.1002/ijc.20970

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  41 in total

1.  The Role of Chlamydia trachomatis in High-Risk Human Papillomavirus Persistence Among Female Sex Workers in Nairobi, Kenya.

Authors:  Nadja Vielot; Michael G Hudgens; Nelly Mugo; Michael Chitwa; Joshua Kimani; Jennifer Smith
Journal:  Sex Transm Dis       Date:  2015-06       Impact factor: 2.830

Review 2.  Human papillomavirus: what every provider should know.

Authors:  Britt K Erickson; Ronald D Alvarez; Warner K Huh
Journal:  Am J Obstet Gynecol       Date:  2012-09-14       Impact factor: 8.661

3.  The effect of intrauterine devices on acquisition and clearance of human papillomavirus.

Authors:  Sarah H Averbach; Yifei Ma; Karen Smith-McCune; Stephen Shiboski; Anna B Moscicki
Journal:  Am J Obstet Gynecol       Date:  2016-12-14       Impact factor: 8.661

4.  Chlamydia Trachomatis and Human Papillomavirus Serostatus in Puerto Rican Women.

Authors:  Maira A Castañeda-Avila; Erick Suárez-Pérez; Raúl Bernabe-Dones; Elizabeth R Unger; Gitika Panicker; Ana P Ortiz
Journal:  P R Health Sci J       Date:  2020-03       Impact factor: 0.705

5.  Chlamydia trachomatis infection and human papillomavirus in women with cervical neoplasia in Pernambuco-Brazil.

Authors:  Mayara Costa Mansur Tavares; Jamilly Lopes de Macêdo; Sérgio Ferreira de Lima Júnior; Sandra de Andrade Heráclio; Melânia Maria Ramos Amorim; Maria de Mascena Diniz Maia; Paulo Roberto Eleutério de Souza
Journal:  Mol Biol Rep       Date:  2014-01-07       Impact factor: 2.316

Review 6.  Cervical Cancer Induction Enhancement Potential of Chlamydia Trachomatis: A Systematic Review.

Authors:  Safae Karim; Tiatou Souho; Mohamed Benlemlih; Bahia Bennani
Journal:  Curr Microbiol       Date:  2018-01-22       Impact factor: 2.188

7.  A highly sensitive, multiplex broad-spectrum PCR-DNA-enzyme immunoassay and reverse hybridization assay for rapid detection and identification of Chlamydia trachomatis serovars.

Authors:  Koen D Quint; Leen-Jan van Doorn; Bernhard Kleter; Maurits N C de Koning; Henk A M van den Munckhof; Servaas A Morre; Bram ter Harmsel; Elisabete Weiderpass; Gonneke Harbers; Willem J G Melchers; Wim G V Quint
Journal:  J Mol Diagn       Date:  2007-09-14       Impact factor: 5.568

8.  Centrosome abnormalities during a Chlamydia trachomatis infection are caused by dysregulation of the normal duplication pathway.

Authors:  Kirsten A Johnson; Ming Tan; Christine Sütterlin
Journal:  Cell Microbiol       Date:  2009-03-12       Impact factor: 3.715

9.  Evaluation of a novel PCR-based assay for detection and identification of Chlamydia trachomatis serovars in cervical specimens.

Authors:  Koen Quint; Carolina Porras; Mahboobeh Safaeian; Paula González; Allan Hildesheim; Wim Quint; Leen-Jan van Doorn; Sandra Silva; Willem Melchers; Mark Schiffman; Ana Cecilia Rodríguez; Sholom Wacholder; Enrique Freer; Bernal Cortes; Rolando Herrero
Journal:  J Clin Microbiol       Date:  2007-10-24       Impact factor: 5.948

Review 10.  Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis.

Authors:  Anne F Rositch; Jill Koshiol; Michael G Hudgens; Hilda Razzaghi; Danielle M Backes; Jeanne M Pimenta; Eduardo L Franco; Charles Poole; Jennifer S Smith
Journal:  Int J Cancer       Date:  2012-10-11       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.